ライブラリ登録: Guest
Critical Reviews™ in Eukaryotic Gene Expression

年間 6 号発行

ISSN 印刷: 1045-4403

ISSN オンライン: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Parathyroid Hormone-Related Protein in Prostate Cancer

巻 15, 発行 1, 2005, pp. 15-28
DOI: 10.1615/CritRevEukaryotGeneExpr.v15.i1.20
Get accessGet access

要約

Although originally discovered as the peptide responsible for humoral hypercalcemia of malignancy (HHM), parathyroid hormone-related protein (PTHrP) has been shown to play a major role in fetal development. In the adult, it is widely distributed in normal and various cancer tissues. In spite of the rarity of HHM in prostate cancer, PTHrP is widely distributed in prostate cancer cells. PTHrP is a precursor molecule with generation of various fragments with distinct biological activities. More recent studies have shown that there is intranuclear localization of PTHrP and that intracrine effects of the peptide are involved in promoting processes that result in tumor progression (cell proliferation, apoptosis, cell attachment and angiogenesis) in prostate cancer. PTHrP expression is controlled by three distinct promoters, with P3 being used most often in cancer cells. The factors that control PTHrP production via interaction with the promoters are growth factors, androgens, vitamin D analogs, and adenoviral proteins. TGF-β and its effector Smad3 activate the P3 promoter through an AGAC box and an Ets binding site involving Ets1 and to some extent Ets2 proteins. In addition, TGF-β stimulates P3 promoter activity via Smad-independent pathways that involve the p38 MAP kinase. Although the addition of PTHrP or transfection with the PTHrP gene in prostate cells results in effects that promote tumor development, studies that employ inhibition of PTHrP activity in vitro and in vivo are needed to establish a definitive role of this peptide in the pathogenesis of prostate cancer.

によって引用された
  1. Asadi Farrokh K., Kukreja Subhash C., Boyer Brigitte, Valess Ana-Maria, Cook James L., E1A oncogene expression inhibits PTHrP P3 promoter activity and sensitizes human prostate cancer cells to TNF-induced apoptosis, International Urology and Nephrology, 42, 4, 2010. Crossref

  2. Maass Philipp G., Wirth Jutta, Aydin Atakan, Rump Andreas, Stricker Sigmar, Tinschert Sigrid, Otero Miguel, Tsuchimochi Kaneyuki, Goldring Mary B., Luft Friedrich C., Bähring Sylvia, A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E, Human Molecular Genetics, 19, 5, 2010. Crossref

  3. Shukeir Nicholas, Garde Seema, Wu Jinzi J., Panchal Chandra, Rabbani Shafaat A., Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer, Anti-Cancer Drugs, 16, 10, 2005. Crossref

  4. Alonso V., Pérez-Martínez F.C., Calahorra F.J., Esbrit P., Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells, Life Sciences, 85, 11-12, 2009. Crossref

  5. Agirregoitia Naiara, Casis Luis, Gil Javier, Ruiz Fátima, Irazusta Jon, Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues, Regulatory Peptides, 139, 1-3, 2007. Crossref

  6. Antoniou Antonis C, Kuchenbaecker Karoline B, Soucy Penny, Beesley Jonathan, Chen Xiaoqing, McGuffog Lesley, Lee Andrew, Barrowdale Daniel, Healey Sue, Sinilnikova Olga M, Caligo Maria A, Loman Niklas, Harbst Katja, Lindblom Annika, Arver Brita, Rosenquist Richard, Karlsson Per, Nathanson Kate, Domchek Susan, Rebbeck Tim, Jakubowska Anna, Lubinski Jan, Jaworska Katarzyna, Durda Katarzyna, Złowowcka-Perłowska Elżbieta, Osorio Ana, Durán Mercedes, Andrés Raquel, Benítez Javier, Hamann Ute, Hogervorst Frans B, van Os Theo A, Verhoef Senno, Meijers-Heijboer Hanne EJ, Wijnen Juul, Gómez Garcia Encarna B, Ligtenberg Marjolijn J, Kriege Mieke, Collée J Margriet, Ausems Margreet GEM, Oosterwijk Jan C, Peock Susan, Frost Debra, Ellis Steve D, Platte Radka, Fineberg Elena, Evans D Gareth, Lalloo Fiona, Jacobs Chris, Eeles Ros, Adlard Julian, Davidson Rosemarie, Cole Trevor, Cook Jackie, Paterson Joan, Douglas Fiona, Brewer Carole, Hodgson Shirley, Morrison Patrick J, Walker Lisa, Rogers Mark T, Donaldson Alan, Dorkins Huw, Godwin Andrew K, Bove Betsy, Stoppa-Lyonnet Dominique, Houdayer Claude, Buecher Bruno, de Pauw Antoine, Mazoyer Sylvie, Calender Alain, Léoné Mélanie, Bressac- de Paillerets Brigitte, Caron Olivier, Sobol Hagay, Frenay Marc, Prieur Fabienne, Ferrer Sandra Fert, Mortemousque Isabelle, Buys Saundra, Daly Mary, Miron Alexander, Terry Mary Beth, Hopper John L, John Esther M, Southey Melissa, Goldgar David, Singer Christian F, Fink-Retter Anneliese, Tea Muy-Kheng, Kaulich Daphne Geschwantler, Hansen Thomas VO, Nielsen Finn C, Barkardottir Rosa B, Gaudet Mia, Kirchhoff Tomas, Joseph Vijai, Dutra-Clarke Ana, Offit Kenneth, Piedmonte Marion, Kirk Judy, Cohn David, Hurteau Jean, Byron John, Fiorica James, Toland Amanda E, Montagna Marco, Oliani Cristina, Imyanitov Evgeny, Isaacs Claudine, Tihomirova Laima, Blanco Ignacio, Lazaro Conxi, Teulé Alex, Valle J Del, Gayther Simon A, Odunsi Kunle, Gross Jenny, Karlan Beth Y, Olah Edith, Teo Soo-Hwang, Ganz Patricia A, Beattie Mary S, Dorfling Cecelia M, van Rensburg Elizabeth Jansen, Diez Orland, Kwong Ava, Schmutzler Rita K, Wappenschmidt Barbara, Engel Christoph, Meindl Alfons, Ditsch Nina, Arnold Norbert, Heidemann Simone, Niederacher Dieter, Preisler-Adams Sabine, Gadzicki Dorothea, Varon-Mateeva Raymonda, Deissler Helmut, Gehrig Andrea, Sutter Christian, Kast Karin, Fiebig Britta, Schäfer Dieter, Caldes Trinidad, de la Hoya Miguel, Nevanlinna Heli, Muranen Taru A, Lespérance Bernard, Spurdle Amanda B, Neuhausen Susan L, Ding Yuan C, Wang Xianshu, Fredericksen Zachary, Pankratz Vernon S, Lindor Noralane M, Peterlongo Paolo, Manoukian Siranoush, Peissel Bernard, Zaffaroni Daniela, Bonanni Bernardo, Bernard Loris, Dolcetti Riccardo, Papi Laura, Ottini Laura, Radice Paolo, Greene Mark H, Loud Jennifer T, Andrulis Irene L, Ozcelik Hilmi, Mulligan Anna Marie, Glendon Gord, Thomassen Mads, Gerdes Anne-Marie, Jensen Uffe B, Skytte Anne-Bine, Kruse Torben A, Chenevix-Trench Georgia, Couch Fergus J, Simard Jacques, Easton Douglas F, Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers, Breast Cancer Research, 14, 1, 2012. Crossref

  7. Seeman Ego, Strewler Gordon J, Clinical and basic research papers – April 2005 selections, BoneKEy-Osteovision, 2, 5, 2005. Crossref

  8. Smith A.M., Findlay V.J., Bandurraga S.G., Kistner-Griffin E., Spruill L.S., Liu A., Golshayan A.R., Turner D.P., ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype, Carcinogenesis, 33, 3, 2012. Crossref

  9. Susa Takao, Ikaga Reina, Kajitani Takashi, Iizuka Masayoshi, Okinaga Hiroko, Tamamori‐Adachi Mimi, Okazaki Tomoki, Wild‐type and specific mutant androgen receptor mediates transcription via 17β‐estradiol in sex hormone‐sensitive cancer cells, Journal of Cellular Physiology, 230, 7, 2015. Crossref

  10. McCarty Mark F., Block Keith I., Toward a Core Nutraceutical Program for Cancer Management, Integrative Cancer Therapies, 5, 2, 2006. Crossref

  11. Furesi Giulia, Rauner Martina, Hofbauer Lorenz C., Emerging Players in Prostate Cancer–Bone Niche Communication, Trends in Cancer, 7, 2, 2021. Crossref

  12. Yoshida Go J., Saya Hideyuki, Molecular pathology underlying the robustness of cancer stem cells, Regenerative Therapy, 17, 2021. Crossref

  13. Schwartz Gary G., Prostate Cancer, Serum Parathyroid Hormone, and the Progression of Skeletal Metastases, Cancer Epidemiology, Biomarkers & Prevention, 17, 3, 2008. Crossref

近刊の記事

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain